lifestyle.longislandreport.org

  • Animals
  • Auto
  • Beauty & Style
  • Business News
  • Entertainment
  • Food
  • Health
  • Home & Family
  • Podcasts
  • Tech
  • Travel

Business

Latest Business News

  • enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness

    enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness

    Business Wire
    December 2, 2025
  • ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

    ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

    Business Wire
    December 2, 2025
  • Tech Against Scams Coalition Launches “Scamberry Pie” to Spark Holiday Conversations About Online Safety

    Tech Against Scams Coalition Launches “Scamberry Pie” to Spark Holiday Conversations About Online Safety

    Business Wire
    December 2, 2025
  • Ryder Sets New Giving Record with $1.17 Million Donation to United Way

    Ryder Sets New Giving Record with $1.17 Million Donation to United Way

    Business Wire
    December 2, 2025
  • MUNCHKIN Named to Inc.’s 2025 Best in Business List in BEST IN INNOVATION

    MUNCHKIN Named to Inc.’s 2025 Best in Business List in BEST IN INNOVATION

    Business Wire
    December 2, 2025
  • Hirsch Unifies Global Security Operations Under One Trusted Brand

    Hirsch Unifies Global Security Operations Under One Trusted Brand

    Business Wire
    December 2, 2025
  • Owens & Minor to Present at Upcoming Investor Conferences on December 2, 2025

    Owens & Minor to Present at Upcoming Investor Conferences on December 2, 2025

    Business Wire
    December 2, 2025
  • The Estée Lauder Companies and Jo Malone London Introduce AI-Powered Scent Advisor Experience

    The Estée Lauder Companies and Jo Malone London Introduce AI-Powered Scent Advisor Experience

    Business Wire
    December 2, 2025
  • CatalYm Announces First Patient Dosed in Phase 2b Trial Evaluating Visugromab in Combination with Chemoimmunotherapy as Second-Line Treatment in Metastatic Non-squamous NSCLC

    CatalYm Announces First Patient Dosed in Phase 2b Trial Evaluating Visugromab in Combination with Chemoimmunotherapy as Second-Line Treatment in Metastatic Non-squamous NSCLC

    Business Wire
    December 2, 2025
  • Fischer Identity to Present at 2025 Gartner Identity & Access Management Summit in Grapevine, TX

    EIN Newswire
    December 2, 2025
Prev
1 … 20,944 20,945 20,946 20,947 20,948 … 31,751
Next

Channels

Follow Us

  • X
  • LinkedIn

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.